Ana I. Extremera

VAV3 mediates resistance to breast cancer endocrine therapy

F. Climent, Yusuke Nakamura, M. Esteller, 2014, Breast Cancer Research.

Immune Cell Associations with Cancer Risk

A. Antoniou, T. Mak, J. Dopazo, 2020, iScience.

Modification of BRCA1-associated breast cancer risk by HMMR overexpression

C. Lázaro, R. Khokha, C. Eaves, 2022, Nature Communications.

Altered regulation of BRCA1 exon 11 splicing is associated with breast cancer risk in carriers of BRCA1 pathogenic variants

E. Eyras, A. Spurdle, X. Puente, 2021, Human mutation.

Lymphangioleiomyomatosis Biomarkers Linked to Lung Metastatic Potential and Cell Stemness

F. Climent, M. Esteller, J. Serra-Musach, 2015, PloS one.

Histamine signaling and metabolism identify potential biomarkers and therapies for lymphangioleiomyomatosis

M. Ferrer, B. Saez, C. La Motta, 2021, EMBO molecular medicine.